Target intelligence / Profile preview

Caveolin-1–Nuclear factor erythroid 2-related factor 2 signaling axis (CAV1–Nrf2 axis)

Target
CAV1–Nrf2 axis
Molecular classification
Scaffolding protein, Transcription factor, Signaling complex, Redox regulator
01

Overview

The Caveolin-1–Nuclear factor erythroid 2-related factor 2 (CAV1–Nrf2) signaling axis is a critical regulatory mechanism that links plasma membrane structural integrity with the cellular antioxidant response [PubMed: 22416018]. Caveolin-1, a primary scaffolding protein of caveolae, directly interacts with the transcription factor Nrf2, typically sequestering it in the cytoplasm and inhibiting its ability to drive the expression of cytoprotective genes [UniProt: P14416]. This interaction is mediated by the caveolin-scaffolding domain (CSD) of CAV1 and the Nrf2-ECH homology (Neh) domains of Nrf2 [PubMed: 28636914]. Dysregulation of this axis is implicated in various pathologies; for instance, loss of CAV1 can lead to constitutive Nrf2 activation, which may promote chemoresistance in cancer cells, while CAV1 overexpression can suppress Nrf2, exacerbating oxidative damage in conditions like pulmonary fibrosis and cardiovascular disease [NCBI: PMC4688118]. Therapeutic interventions targeting this axis generally utilize Nrf2 activators, such as Sulforaphane or Bardoxolone methyl, to disrupt inhibitory complexes and restore redox homeostasis [PubMed: 23972477]. Understanding the balance within this axis is crucial for developing targeted therapies that address oxidative damage without inadvertently promoting tumor cell survival.

Other names
CAV1-Nrf2 pathwayCaveolin-1/NFE2L2 signaling axisCAV1-NFE2L2 complexCaveolin-1-Nrf2 interaction
02

Mechanism of action

The mechanism of action involves the pharmacological disruption of the inhibitory interaction between Caveolin-1 and Nrf2, or the modification of Keap1, leading to the stabilization and nuclear translocation of Nrf2 [PubMed: 22416018]. Once in the nucleus, Nrf2 binds to the Antioxidant Response Element (ARE) in the promoter regions of target genes, inducing the transcription of antioxidant and phase II detoxification enzymes such as Heme oxygenase-1 (HO-1) and NAD(P)H quinone dehydrogenase 1 (NQO1) [NCBI: PMC4688118].

03

Biological functions

Redox homeostasisOxidative stress responseSignal transductionCell survivalProteostasis
04

Disease associations

CancerPulmonary fibrosisCardiovascular diseaseNeurodegenerative diseaseChronic obstructive pulmonary disease (COPD)Inflammation
05

Safety considerations

Nrf2-mediated chemoresistance in cancer cells (the Nrf2 paradox) [PubMed: 24011515]Cardiovascular complications including heart failure and fluid retention [PubMed: 23972477]Potential for off-target effects due to systemic redox modulation
06

Interacting drugs

Sulforaphane [PubMed: 22416018]

5 more in the full profile.

07

Biomarkers

Heme oxygenase-1 (HO-1) expression [PubMed: 22416018]NAD(P)H quinone dehydrogenase 1 (NQO1) expression [NCBI: PMC4688118]Caveolin-1 protein levels [PubMed: 28636914]Nrf2 nuclear translocation [PubMed: 22416018]

Beyond the preview

Go deeper on Caveolin-1–Nuclear factor erythroid 2-related factor 2 signaling axis (CAV1–Nrf2 axis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caveolin-1–Nuclear factor erythroid 2-related factor 2 signaling axis (CAV1–Nrf2 axis).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call